
About Provet Pharma
Provet Pharma is an Agriculture company based in Chennai (India) founded in 2009. Producer and supplier of animal feed and nutrition products. The company has 116 employees. Its Indian entity Provet Pharma Private Limited reported revenue of βΉ101 Cr. Provet Pharma offers products and services including Avinova and Blunova. Its focus areas include Food and Agriculture and Animal Feed and Nutrition.
Company details
Provet Pharma Private Limited was established in 2009 in Chennai, India. Products focused on animal health and nutrition are produced and distributed for livestock and aquaculture sectors. Operations center on supplying feed and related solutions to support these industries. The company is led by Managing Director Muthu Selvan, with activities based primarily in India.
- Annual Revenue₹101 Cr
FY 2025 · +35% YoY
- Net Profit₹1.30 Cr
FY 2025 · 1% margin
- EBITDA₹4.43 Cr
FY 2025 · 4% margin
- Investors
- Employee Count116
Associated legal entities of Provet Pharma
Provet Pharma operates through Provet Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Provet Pharma Private Limited CIN U24231TN2009PTC073198 | Active | 14 Oct 2009 | Chennai, Tamil Nadu | ₹101 Cr | 116 | 2 | View details |
Products & Services of Provet Pharma
Provet Pharma offers a comprehensive portfolio of products and services, including Avinova and Blunova.
Avinova is utilized for addressing healthcare needs in poultry through various formulations like antibacterials and disinfectants
Blunova is employed for managing aquaculture health requirements, including disinfectants and feed additives
Apps and channels of Provet Pharma
its YouTube channel Provet Pharma Private Limited has 595 subscribers and 30 videos.
Videos from Provet Pharma
The most watched videos on Provet Pharma's YouTube channel, Provet Pharma Private Limited (595 subscribers). Click a video to play it here.
More on Provet Pharma Private Limited.
Funding Insights of Provet Pharma
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Provet Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2022 | Seed | β | β |
1 investors in total: 1 institutional.
Investors in Provet Pharma
Provet Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include N+1 Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Revenue-based growth capital is provided for Indian entrepreneurs. | np1.in | Delhi, India |
Investor details for Provet Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Provet Pharma Private Limited (Provet Pharma)
Provet Pharma Private Limited is the primary company behind Provet Pharma. The board of Provet Pharma Private Limited currently have 2 directors; the longest-serving is Muthu Selvan Vengan, appointed in 2009. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Muthu Selvan Vengan DIN 02765324 | Managing Director | 14 Oct 2009 | 17 yrs | Provet Pharma Private Limited |
| Suthanthirakumar Senthil DIN 02776069 | Director | 14 Oct 2009 | 17 yrs | Provet Pharma Private Limited |
People of Provet Pharma
1 people are tracked at Provet Pharma (1 in leadership); the tracked headcount is 116.
| Name | Role | Group |
|---|---|---|
| Managing Director | Leadership |
Complete people profiles for Provet Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Provet Pharma
Figures of Provet Pharma Private Limited, the primary company behind Provet Pharma, for FY 2025. Revenue was ₹101 Cr (+35% year on year). Net profit was ₹1.30 Cr (1% margin). EBITDA was ₹4.43 Cr (4% margin). Revenue has grown at a compounded annual rate of 0% over three years and +14% over five years.
- ₹101 CrRevenue · FY 2025 · +35% YoY
- ₹1.30 CrNet profit · 1% margin
- ₹4.43 CrEBITDA · 4% margin
- ₹25 LakhPaid-up capital
- 116Employees (provident fund records)
- 0%Revenue CAGR, 3 years
- +14%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Provet Pharma Private Limited are on its company page.
Detailed financial statements for Provet Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Provet Pharma
2 dated milestones of Provet Pharma across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Provet Pharma is founded.
- Funding First funding round.
Web traffic of Provet Pharma
The website of Provet Pharma (provet.in) receives about 1.3K visits a month.
- Monthly visits1.3K
▼ 6.9% vs previous month
Top companies in Animal Feed & Nutrition
3 companies that operate in the same segment as Provet Pharma (Animal Feed & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Procures and distributes milk and dairy products through unions and online orders. | 1984 | Bengaluru, Karnataka, India | USD 2.58 M | |||
A brand specializing in high-quality milk and food products. | 2007 | Lucknow, Uttar Pradesh, India | USD 184.73 M | 1,016 | ||
Provides healthy snack options including potato chips, multigrain chips, and noodles for consumers. | 2016 | Kolkata, West Bengal, India | USD 51.28 M | 388 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Provet Pharma
Complete news archive for Provet Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Provet Pharma
Provet Pharma was founded in 2009 and raised its 1st funding round 13 years after it was founded.
Provet Pharma is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Provet Pharma has 116 employees.
The primary company behind Provet Pharma, Provet Pharma Private Limited, reported revenue of βΉ101 Cr for FY 2025, up 35% year on year.
Provet Pharma Private Limited was established in 2009 in Chennai, India. Products focused on animal health and nutrition are produced and distributed for livestock and aquaculture sectors. Operations center on supplying feed and related solutions to support these industries. The company is led by Managing Director Muthu Selvan, with activities based primarily in India.
Provet Pharma offers Avinova and Blunova.
Provet Pharma has 1 investor. Key investors include N+1 Capital.
Provet Pharma operates through Provet Pharma Private Limited.
The legal entities of Provet Pharma currently have 2 directors, including Muthu Selvan Vengan, Suthanthirakumar Senthil.
